Tetrahydrozoline Hydrochloride

CHEMBL1200413 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
236.7 g/mol
LogP
Phase
4

Tetrahydrozoline hydrochloride is the hydrochloride salt form of tetrahydrozoline, an alpha-adrenergic agonist decongestant and ocular vasoconstrictant. See tetrahydrozoline for complete pharmacological details. This salt form provides improved stability and solubility in aqueous ophthalmic and nasal formulations.

Molekularmasse

236,7400 g/mol

TPSA

24,40 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.c1ccc2c(c1)CCCC2C1=NCCN1

InChI

InChI=1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H

Molecular Formula

C13H17ClN2

HBD / HBA

2 / 1

Rotierbare Bindungen

1

Schwere Atome

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Tetrahydrozoline hydrochloride is the hydrochloride salt form of tetrahydrozoline, an alpha-adrenergic agonist decongestant and ocular vasoconstrictant. See tetrahydrozoline for complete pharmacological details. This salt form provides improved stability and solubility in aqueous ophthalmic and nasal formulations.

Yes, Tetrahydrozoline Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200413. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10648. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.